The pharmaceutical large narrowed its full-year steering after its blockbuster Wegovy weight-loss drug beat gross sales expectations within the third quarter.
in Business
Novo Nordisk's Wegovy Sales Beat Expectations
Henkel Backs Guidance After Sales Rise
